Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria-Reference-Cited by-同舟云学术

Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria

Published:2016-02 Issue:2 Volume:69 Page:109-116
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Campos Carlos M.,Garcia-Garcia Hector M.,Muramatsu Takashi,de Araujo Gonçalves Pedro,Onuma Yoshinobu,Dudek Dariusz,Thuesen Leif,Webster Mark W.I.,Kitslaar Pieter,Veldhof Susan,Reiber Johan H.C.,Nieman Koen,Ormiston John A.,Serruys Patrick W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?;Serruys;Eur Heart J.,2012

2. Biodegradable stents: they do their job and disappear;Waksman;J Invasive Cardiol.,2006

3. Assessing bioresorbable coronary devices: methods and parameters;Garcia-Garcia;JACC Cardiovasc Imaging.,2014

4. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months;Serruys;EuroIntervention.,2014

5. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial;Onuma;JACC Cardiovasc Interv.,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angina e isquemia a los 2 años con armazón vascular bioabsorbible y stents farmacoactivos metálicos. Estudio ESTROFA Isquemia AVB-SFAm;Revista Española de Cardiología;2018-05

2. Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study;Revista Española de Cardiología (English Edition);2018-05

3. Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SP;Catheterization and Cardiovascular Interventions;2017-05-04

4. Comparative assessment of “plaque/media” change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study;The International Journal of Cardiovascular Imaging;2016-12-23

5. Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation;Revista Española de Cardiología (English Edition);2016-12